Aclaris To Host R&D And Investor Event On October 4, 2017 In New York Post author:Sam Post published:September 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Former Pfizer Neuroscientist to Helm New York Biotech March 30, 2017 Teva Announces The Launch Of Generic Vagifem In The United States July 24, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017